Stockreport

Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response [Yah...

Precigen, Inc.  (PGEN) 
Last precigen, inc. earnings: 3/2 04:05 pm Check Earnings Report
PDF – 51% (18 out of 35) of patients achieved Complete Response, requiring no surgeries after treatment with PRGN-2012; complete responses have been durable beyond 12 month [Read more]